Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Gene therapy for AIDS: current trends]

K Takatsuki1, K Obaru, K Yoshimura

  • 1Second Department of Internal Medicine, Kumamoto University School of Medicine.

Nihon Rinsho. Japanese Journal of Clinical Medicine
|January 1, 1996
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

[Anti-HIV drugs and drug delivery system].

Nihon rinsho. Japanese journal of clinical medicine·1998
Same author

The V1/V2 region of human immunodeficiency virus type 1 modulates the sensitivity to neutralization by soluble CD4 and cellular tropism.

AIDS research and human retroviruses·1997
Same author

Characterization of proviral DNA from an individual with long-term, nonprogressive infection with HIV-1 and nonrecoverable virus.

Journal of acquired immune deficiency syndromes and human retrovirology : official publication of the International Retrovirology Association·1997
Same author

Gene therapy for adult T cell leukemia using human immunodeficiency virus vector carrying the thymidine kinase gene of herpes simplex virus type 1.

Human gene therapy·1996
Same author

Expression of AML1 and ETO Transcripts in hematopoietic cells.

Leukemia·1995
Same author

Neutralizing monoclonal antibodies against human immunodeficiency virus type 2 gp120.

Journal of virology·1995

Gene therapy offers a promising approach for treating infectious diseases like HIV by modifying somatic cells. This strategy aims to reduce viral load or stimulate immune responses, with ongoing clinical trials demonstrating its potential.

Area of Science:

  • Biotechnology
  • Immunology
  • Virology

Context:

  • Genetic manipulation of somatic cells presents a novel therapeutic avenue for infectious diseases.
  • Human immunodeficiency virus (HIV) infection is a primary target for gene-based therapeutic strategies.
  • Existing research demonstrates the principle of gene therapy for HIV in laboratory settings.

Purpose:

  • To explore the therapeutic potential of genetic manipulation in somatic cells for infectious diseases, focusing on HIV.
  • To investigate methods for reducing viral burden and immune dysfunction in HIV-infected individuals through gene insertion.
  • To assess the feasibility of inducing antiviral immune responses via ectopic gene expression for vaccine development.

Summary:

  • Stable insertion of "resistance genes" into susceptible cells can lower HIV viral load and mitigate immune decline.

Related Experiment Videos

  • Ectopic expression of viral antigens may elicit strong immune responses, forming the basis for new vaccines.
  • While laboratory studies are promising, further preclinical and clinical evaluations are essential to confirm therapeutic benefits.

    • Impact:

    • Over 400 patients have been treated with gene therapy in the US, indicating clinical progress.
    • Japan has established a committee for gene therapy and recently approved ADA gene therapy, signaling advancements.
    • The development of gene therapy for HIV in Japan is anticipated in the near future, highlighting global progress.